The Congenital Hematological Disease Drug market was valued at USD 132.22 Million in 2025 and is expected to reach USD 311.36 Million by 2033, growing at a CAGR of 11.3% (2025-2033). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.